X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (92919) 92919
Newspaper Article (1260) 1260
Newsletter (411) 411
Book Chapter (192) 192
Book / eBook (66) 66
Magazine Article (64) 64
Dissertation (48) 48
Publication (36) 36
Conference Proceeding (21) 21
Web Resource (14) 14
Government Document (11) 11
Reference (11) 11
Book Review (5) 5
Trade Publication Article (5) 5
Journal / eJournal (4) 4
Transcript (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (69835) 69835
chemotherapy (61544) 61544
female (52818) 52818
oncology (51691) 51691
cancer (42202) 42202
middle aged (40966) 40966
aged (35375) 35375
male (33919) 33919
adult (32143) 32143
surgery (24635) 24635
treatment outcome (20846) 20846
prognosis (20375) 20375
survival (18928) 18928
breast cancer (18699) 18699
chemotherapy, adjuvant (18676) 18676
care and treatment (18133) 18133
antineoplastic combined chemotherapy protocols - therapeutic use (16683) 16683
neoplasm staging (15898) 15898
tumors (15289) 15289
retrospective studies (15275) 15275
metastasis (14614) 14614
cancer therapies (14393) 14393
radiotherapy (14110) 14110
aged, 80 and over (13980) 13980
medicine & public health (13587) 13587
research (12952) 12952
analysis (12860) 12860
patients (12105) 12105
therapy (11306) 11306
adjuvant chemotherapy (11172) 11172
disease-free survival (11137) 11137
carcinoma (10966) 10966
health aspects (10670) 10670
breast neoplasms - drug therapy (10312) 10312
combined modality therapy (10158) 10158
survival rate (9767) 9767
survival analysis (9551) 9551
medical prognosis (9457) 9457
follow-up studies (9429) 9429
breast neoplasms - pathology (8423) 8423
radiation therapy (8115) 8115
risk factors (7872) 7872
antineoplastic agents - therapeutic use (7675) 7675
colorectal cancer (7550) 7550
hematology, oncology and palliative medicine (6466) 6466
studies (6356) 6356
clinical trials (6326) 6326
cisplatin (6315) 6315
neoadjuvant therapy (6305) 6305
adjuvant treatment (6237) 6237
adolescent (5879) 5879
trial (5850) 5850
radiotherapy, adjuvant (5811) 5811
young adult (5798) 5798
neoadjuvant chemotherapy (5794) 5794
patient outcomes (5758) 5758
animals (5676) 5676
expression (5635) 5635
drug therapy (5543) 5543
radiation-therapy (5508) 5508
cancer patients (5489) 5489
diagnosis (5425) 5425
prospective studies (5424) 5424
metastases (5402) 5402
medical research (5401) 5401
kaplan-meier estimate (5377) 5377
antineoplastic combined chemotherapy protocols - adverse effects (5360) 5360
apoptosis (5271) 5271
oncology, experimental (5230) 5230
multivariate analysis (5179) 5179
time factors (5001) 5001
women (4854) 4854
medicine (4829) 4829
gene expression (4792) 4792
mortality (4790) 4790
adenocarcinoma (4779) 4779
recurrence (4770) 4770
fluorouracil - administration & dosage (4620) 4620
lymphatic metastasis (4603) 4603
radiation (4595) 4595
management (4574) 4574
immunohistochemistry (4556) 4556
radiology, nuclear medicine & medical imaging (4462) 4462
fluorouracil (4430) 4430
research article (4366) 4366
usage (4300) 4300
development and progression (4291) 4291
quality of life (4266) 4266
cancer research (4231) 4231
breast-cancer (4198) 4198
antineoplastic combined chemotherapy protocols - administration & dosage (4092) 4092
proteins (4086) 4086
toxicity (4065) 4065
genetic aspects (4060) 4060
proportional hazards models (4008) 4008
randomized-trial (3993) 3993
pharmacology & pharmacy (3970) 3970
lung cancer (3961) 3961
cisplatin - administration & dosage (3894) 3894
cell line, tumor (3859) 3859
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (16) 16
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (10) 10
Online Resources - Online (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Gerstein Science - Pharmacy (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Media Commons - Microtexts (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Sunnybrook Stacks (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Oshawa (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (93059) 93059
German (779) 779
French (576) 576
Japanese (501) 501
Chinese (293) 293
Russian (237) 237
Spanish (192) 192
Portuguese (120) 120
Polish (101) 101
Hungarian (97) 97
Italian (78) 78
Korean (59) 59
Turkish (29) 29
Dutch (27) 27
Norwegian (23) 23
Romanian (20) 20
Danish (12) 12
Slovenian (12) 12
Ukrainian (11) 11
Bulgarian (10) 10
Czech (9) 9
Finnish (8) 8
Lithuanian (8) 8
Hebrew (7) 7
Arabic (6) 6
Persian (6) 6
Icelandic (5) 5
Serbian (3) 3
Croatian (2) 2
Latvian (2) 2
Swedish (2) 2
Afrikaans (1) 1
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2010, Volume 46, Issue 13, pp. 2422 - 2431
Journal Article
Journal Article
BMC cancer, ISSN 1471-2407, 2018, Volume 18, Issue 1, pp. 877 - 12
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 19, pp. 1813 - 1823
In patients with surgically resected melanoma, those with BRAF mutations who received 1 year of oral adjuvant therapy with dabrafenib and trametinib had a 53... 
HIGH-RISK MELANOMA | SURVIVAL | MEDICINE, GENERAL & INTERNAL | INTERFERON-ALPHA-2B | PLACEBO | THERAPY | MEK INHIBITION | PHASE-III | DOUBLE-BLIND | HAZARD | IPILIMUMAB | Skin Neoplasms - drug therapy | Oximes - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Oximes - therapeutic use | Male | Adjuvants, Immunologic - adverse effects | Young Adult | Melanoma - genetics | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Imidazoles - therapeutic use | Adjuvants, Immunologic - therapeutic use | Skin Neoplasms - surgery | Double-Blind Method | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Neoplasm Recurrence, Local | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Adolescent | Survival Analysis | Aged | Pyridones - therapeutic use | Melanoma - surgery | Mutation | Neoplasm Staging | Pyridones - adverse effects | Melanoma - mortality | Usage | Relapse | Patient outcomes | Analysis | Melanoma | Adjuvant treatment | Outcome and process assessment (Health Care) | Reports | Drug therapy | Cancer | Diseases | Medical imaging | Oncology | Metastasis | FDA approval | Kinases | Cancer therapies | Survival | Skin cancer | Metastases | Medical prognosis | Immunotherapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 2, pp. 122 - 131
Journal Article